Jonathan Symonds - 12 May 2021 Form 4 Insider Report for Rubius Therapeutics, Inc.

Role
Director
Signature
/s/ Joanne M. Protano, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
12 May 2021
Net transactions value
$0
Form type
4
Filing time
13 May 2021, 20:35:29 UTC
Next filing
13 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RUBY Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 12 May 2021 Common Stock 25,000 $23.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service.